SS
|
|
|
- ただきよ たかひ
- 7 years ago
- Views:
Transcription
1
2 SS
3 SS
4 SS SS SS SS SS 1 2 SS SS 1 SS
5 HI BHI HI HI 1930 Difco HI BHI BHI HI BHI BHI
6 TSI 1 SS Kauffmann-White
7 HI BHI agar medium nutrient broth nutrient broth Difco Bile Salts No.3 No.2 No.3
8 No.2 No.3 No.3 No.2 No.1 No.2 No SS ml 20
9 SS SS 10 1 SS SS SS SS 1
10 SS SS SS SS HI BHI R PR
11 53
12 3 HI BHI 3 HI BHI
13 SS LAMP SS Clinical Laboratory Medicine
14 SS LAMP LAMP 1 SS
15
16
17 3 4 12
18
19
20 1 3 7
21 1959 4
untitled
NO. 2007 10 10 34 10 10 0570-058-669 http://www.i-nouryoku.com/index.html (40 ) () 1 NO. 2007 10 10 2.2 2.2 130 70 20 80 30 () () 9 10 () 78 8 9 () 2 NO. 2007 10 10 4 7 3 NO. 2007 10 10 40 20 50 2 4 NO.
untitled
-- -- -3- % % % 6% % % 9 66 95 96 35 9 6 6 9 9 5 77 6 6 5 3 9 5 9 9 55 6 5 9 5 59 () 3 5 6 7 5 7 5 5 6 6 7 77 69 39 3 6 3 7 % % % 6% % % (: ) 6 65 79 7 3 36 33 9 9 5 6 7 3 5 3 -- 3 5 6 76 7 77 3 9 6 5
PowerPoint Presentation
2 9/ 3 3 9/ 9 4 5 , PR () 6 ,,, (11) 7 PR 8 9 10 11 TEL. 106 8/131512/291/3 TEL. 107 12/291/3 12 http://www.f-turn.jp/ 13 21 4 21 14 200910 U 200911 U 200911 20102 15 20102 PR 20103 20103 16 20103 20104
17 17 17 17 11 21 28 1 24 12 36 2,000 2 22 11 3.67 3.38 22 2.97 21 10 1.7 1.12 22 10 13 2.75 11 10 15 24 10 12 14 3 17 17 2006 4 17 10 24 12 17 5 15 17 17 11 40 6 17 40 17 11 7 24 17 24 17 8 40 17 17 9
untitled
,337 37 35 0,349,09 35 55 988 3 0 0 3,387 7 90 0,369,46 5 57 5 0 90 38 8,369 3 4 5 6 7 8 9 0 3 4 5 6 7 8 9 0 3 4 5 6 8 9 30 3 3 5,400 7,00 9,000 0,800,600 4,400 6,00 8,000 9,800,600 3,400 5,00 7,000 8,800
,877 61,524 33, ,292, ,653 57,601 95,188 2,416 1,767,
02 02 02 180,771 07 02 01 1,377 07 02 02 1,051,703 07 02 05 220,099 07 03 01 926,597 08 02 04 1,877,566 08 04 02 2,973,603 08 05 03 672,950 10 06 03 778,433 10 06 04 735,789 10 06 06 225,392 10 06 07 365,442
TEL:03-5253-1111 2478 TEL:03-3595-2337 FAX:03-3503-7964 Shigella sonnei 200g 300 500cm 0.2 0.3mm 25g 0.45 m Shigella sonnei 3mL 35 37 18 ml 0.1 ml 10 10 ml 40mL 0.1 200 L 25g 1 225mL 35 37 18 24 Shigella
23 3 11 14 46 9.0 7 10m 40.1m 15,883 2,681 25 4 10 39 40 800 180 24 2425 22 21 24 5 3 21 24 10,899 20,472 13,723 33,007 667 400 79,167 8,620 11,694 10,089 25,131 690 215 56,439 13,614 20,897 15,200 32,213
報告書
1 2 3 4 5 6 7 or 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 2.65 2.45 2.31 2.30 2.29 1.95 1.79 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 60 55 60 75 25 23 6064 65 60 1015
2 94.3 91.3 5.1 7.5 0.0 0.0 0.1 0.5 0.6 0.1 0.1 0.4 21.4% 15.8% 14.8% 15.0% 16.0% 16.5% 0.5% 16.1% 15.2% 16.9% 15.7% 17.1% 18.6% 0.4% 21.4% 15.8% 14.8
15 7 8,000 15 4 1 0 5 15 4 2 15 10 1 15 4 1 6 11 4,500 3,500 16 26 35 27 34 16 2 19 16 2 24 16 3 15 1 2 94.3 91.3 5.1 7.5 0.0 0.0 0.1 0.5 0.6 0.1 0.1 0.4 21.4% 15.8% 14.8% 15.0% 16.0% 16.5% 0.5% 16.1%
1 2 3 4 5 6 140,000 70,000 116,797 120,000 111,322 114,180 60,000 103,204 114,395 115,479 100,000 91,713 106,508 50,000 98,664 40,691 37,846 38,941 80,000 40,000 85,214 34,974 32,328 (29,256 60,000 27,383
新入_本文.smd
52 28 220 28 4 1 017-777-1511 2 2 8 2 9 8 9 47.2% 12.8% 11.5% 6.0% 4 2 (49.6%)(13.0%) (14.7%) (7.4%)(8.4%) (52.3%)(9.1%) (11.4%) (10.0%) 33.0% 23.4% 15.6% 9.6% (26.0%) (18.3%) (46.5%) (30.0%) (20.0%) 2
untitled
21 1 28 () 21 2 10 () 2,000 814 40.7% 65 4 2 30.61 19.23 19.0 7074 105 12.9% 75 121 14.9% 6569 107 13.1% 4 0.5% 6064 99 12.2% 19 0 0.0% 2029 36 4.4% 5559 67 8.2% 3039 107 13.1% 4049 102 12.5% 5054 66 8.1%
( ) () ( ) 12/6
( ) () ( ) 12/6 ( ) 21 20 167 167 25 25 36.08 36.65 0.57 52 73 51 99 142 36.65 138 36.08 2500 99 5000 99 51 158 51 51 52 52 73 110 158 165 165 99 166 48.04 138 36.08 28 11.96 PR 51 52 158 99 52 51 73 52
2 / 7
1 / 7 1.30 1.301.00m 2.00 2.001.00m 1.70 1.701.00m 2.4 2.41.0m 2.0 2.01.0m 1.08 1.20.9m 1.08 1.20.9m 2.5 2.51.0m 2.5 2.51.0m 0.9 1.00.9m 1.44 1.60.9m 2 / 7 ml ml 3 / 7 4 / 7 ) 5 / 7 6 / 7 0798-56-1710
PR
1-4 29 1-13 41 1-23 43 1-39 29 PR 1-42 28 1-46 52 1-49 47 1-51 40 1-64 52 1-66 58 1-72 28 1-74 48 1-81 29 1-93 27 1-95 30 1-97 39 1-98 40 1-100 34 2-1 41 2-5 47 2-105 38 2-108 44 2-110 55 2-111 44 2-114
( ) 47.9 (22.3 )
1993 3 1870 1266 67.7 1992 12 (96.0 ) 20 1.4 30 5.5 40 29.0 50 33.0 60 27.6 40 60 40 60 1 40-60 40-50 40 20 70 ( ) 47.9 (22.3 ) 70.2 15.6 100.0 18 18 2 63.0 11.4 69.0 10.1 10 73.8 20 42.5 (72.6 ) (47.8
2 (1) (2) SCI 2 SCI 2 24 2 12 2
2004 (1) (2) (2) (3) (1) 1 (2) (3) 2 (1) (2) SCI 2 SCI 2 24 2 12 2 100% / 16 2002 2003 http://lin.lin.go.jp/alic/month/dome/1997/nov/chousa.htm (05 612 1315 1618 1922 2329 3039 4049 5059 60 ) =10 b g 1
untitled
9 8 29 () 9 8 29 () 9 11 30 () 10 2 14 () 3 10 7 24 () 10 10 9 () 10 8 2 10 11 14 () 10 12 25 () 40 50 100 1953 11 2 26 11 11 3 29 11 6 10 11 1 12 15 2 3 12 12 10 6 12 4 8 5 55 60 100 100 2 25 15 7 29
１ 食品安全を主な目的とする取組
--a 2003 7 26 3. 3.1-1- 16 2 27 0227012-2-a 23 7 1 82 2 1 7 9 2 ( ) -2- -2-b 19 3 28 18 14701-2-c ) 15 5 2-3- 26 21 7 2 2 7 2 3 7 2 4 10 83 23 3 1 7 2 5 7 2 5-2-d -4- -5 - -3-a -6- -4-a -7- -4-b -8- -5-a
1.0% 53.7% 45.3% 70 20.4% 0.9% 20 9.9% 30 15.9% 60 20.0% 40 19.2% 50 13.7% 21.0% 1.1% 3.0% 5.2% 16.1% 35.3% 0.9% 17.3% 10.6% 13.3% 1.2% 4.8% 20.3% 49.8% 1.2% 12.6% 9.6% 13.4% 28.8% 14.5% 19.8% 1.0% 1 2.7%
-51-
-50- -51- 11 3 28 8 1 24 7 2 36 10 1-52- -53- 1 2-54- 6 1 2 3 4 5 6 6 1 19 5 200 300ml 20 6 400ml -55- -56- 10-57- 4 2 20-58- 2,500-59- -60- -61- 2-62- 6 3-63- 9 68 1 6-64- 3-65- 4-66- 5 6-67- -68- 1 1
2006年3月8日
18 21 1990 2004 2 2005 14 15 2004 1990 2005 2003 300 7 2 1 2005 1972 100 40 6 1972 2004 197 6,500 2004 21 59 100 65 2007 5 2005 30 1.8 535.89 348.33 187.56 2006 2006 5 1 30 1 30 46 46 1 46 1000kl 4 1 100kl
Microsoft Word - Œ{Ł¶.doc
17 59.0% 41.0% 60.8% 76.0%71.9% 65.3% 17 2.6% 3.5% 25.9% 57.3% 16.7% 28.1% 52.2% 11.1% 2.6% =270 18 2 (=199) 1 17 71.0% 76.0% 44.2% 71.9% 36.2% 18.1% 65.3% 16.7% 34.1% 16.3% 47.1% 14.9% 13.8% 5.0% 3.6%
CRPNo30表紙.ai
No.30 2012/6 20126 Clinical Research Professionals No.30 17 18 Clinical Research Professionals No.30 2012 6 20126 Clinical Research Professionals No.30 19 20 Clinical Research Professionals No.30 2012
2
u u u u u u u u u u u 2 s s s 3 s s s s 4 e 5 s s ss s s s s s s s u aa eaa u u u e u 6 7 8 u u 9 u u 0 A A 2 2 3 t 6 t t t t A 2 3 d d d d A A 4 5 444444444444444444444444444 4444444444444444444444444444444444
2
1 2 2005 15 17 21 22 24 25 67 95 3 1 2 3 4 17 4 5 6 7 8 9 PR PR PR 10 11 12 PR 419 844 1,490 950 590 20 12 50 13 12/20 2/28 3/30 14 17 349 666 15 59 6 11 15 17 14 15 15 17 3,525,992 15 59 15 17 18 910
![橡0420報告書最終版.ppt[読み取り専用]](/thumbs/42/22906925.jpg "橡0420報告書最終版.ppt[読み取り専用]")
07.報文_及川ら-二校目.indd
8 01 01 4 4 1 5 16 18 6 006 H 18 4 011 H 6 4 1 5 1 5 007 H 19 5 009 1 5 006 007 009 011 9 10 4 000 H 1 4 5 004 H 16 4 004 009 H 1 5 4 4 5 1 4 006 011 1 1 4m 5m 10m 007 1 7 009 009 1 5 10 1 000kg 10a 006
untitled
i ii iii EC 1-1 1 (1) (2) 3,0005,000 3 1 Web 2 Web 1-1 3 (3) (4) 18111812 (5) (1) (2) Web 4 1-2 1 (3) (4) 1812191 (5) 5 1.1 Web 2-1 6 (1) 2-1 387 2-2 7 (2) Web 57% Web 28% 2-3 (3) 43% 56% 2 50%1 26% 2-2
-1- " " -2- - J -3- -4- -5- -6- -7- -8- -9- 20 50 6 2 U 18 2 1 2 1 1 1 1 2-10- 1 2 1 S S HFC S S S J1 1 S B 3 4 B B A HFC HFC -11- 10 J 4 7 8 18500 10000 GM J 2 2003 8 3000 1 1000 2003 3000 1 T -12- 38000
10 2 2 10 6.5 78 1 65 / 30 / - 2 -
- 1 - 10 2 2 10 6.5 78 1 65 / 30 / - 2 - 3 3 30 8 4 8 6 11 14 45 14 7 8 1-3 - 4 1 () 20 4 9 4 9 3 9 4 PR 4 3-4 - - 5 - PR 15 4 PR 7 8 4 9 10-6 - 9 10 9 10 4 9 10 3 9 10 9 9 9 10 PR 1-7 - PR - 8 - 30 100-9
大学等における社会人の受け入れ状況調査
1 1 2 3 4 - - - - - - 6 8 6 2001 30 7 6 3 30 8 6 1 4 3,6,9,12 4 1 1 E 1 3 13 15 4 3 1 ( ) 8. 6 14 8 6 2002 8 8 3 7 60 1 4 4 32 100 12
紀要No.9_006王_CS.indd
1 2 3 4 5 87 9 2009 1937.1 6 1937.1 2 1937.3 1937.9 73 1941.6 77 1941.10 27 1943.9 1943.10 1944.12 1946.12 1947.1 5 1948.4 L 1949.9 10 1950.10 1953.1 1953.12 1956.5.16 1956.6 1966.9 30 1966.10 1967.4 1967.9
:,, : - 7 -
31 ~ ~ - 6 - :,, : - 7 - (),,,,,,; ~ ~ *1 *2 6,,,~,,~ - 8-32 ,, ( );( ),,,,,, ~ ~ ~,,,, (),,,,, - 9 - 33 ~*~ ~~ ~, ~ ~ ~ ~ ~, ~~,,,, - 10 - BCG () g ) BCG BCG,, 34 ,,,, (),,,,,,,,,,,,,, () ( 3 90 [7 6
一休デイサービスセンター
2770105472 2770105472 2776300135 2776300135 - - 072-274-7219 072-204-7319 http://www.19day.jp/ 072-274-7219 072-204-7319 http://www.19day.jp/ 2007 11 1 45 2007 11 1 45 11 12 4km 10 11 -2- 3-3 - 4 - 5 11
MAWGD08Y 5 5 5 5 5 5 6 5 5 6 6 7 5 6 7L 55L 5L 0L 8L 0.0 6.0.0.0 0.5 8 7 0 0 96ml 7ml 60ml 0ml ml 8ml 7ml 0ml 0ml ml 96 7 60 0 6ml ml 0ml 7ml ml 8ml 7ml 0ml 0ml ml 8 7 0 0 5 6 7 5 6 5 (0)890-750
23 3 11 24 21 24 25 4 28 4 2 7 161 2,692 28 12 14 18 18 380 5 3 1 27 21 21 24 10,899 20,472 13,723 33,007 667 400 79,167 8,620 11,694 10,089 25,131 690 215 56,439 13,614 20,897 15,200 32,213 640 416 82,979
1 2 1 3 2 4 22 NPO PR NPO NPO 22 10 4 2,000kg 1kg 5 2 1 4,000 20,000 26 33 27 24 3 19 24 3 4 3 4 3 () 34 3 4 5 23 3 17 23 20 30 1 1 877g/ 3 24 3 1 1 28 897g/ 33 850g/ 22 23 30 1 1 510g/ 22 23 3 24
d-00
283-0105 298 TEL. 0475-76-0839 FAX. 0475-76-0838 400g 300 4950399167708 14 220g 300 4950399066780 Page 1 300g 200 4950399066766 100 400g 300 4950399167722 350g 160 4950399066735 100 600g 350 4950399167685
CHEMOTHERAPY OCT Fig. 1 Chemical structure of CVA-K
OCT. 1986 Fig. 1 Chemical structure of CVA-K VOL.34 S-4 heart infusion broth (Difco) 37.0 g, Resazurin 0.1% alcoholic solution (Wako) 1.0 ml, L-Cystein-HCl H2O (Wako) 0.5 g, Bact agar (Difco) 1.0 g, Deionized
, 360ml P , 360ml P , 360ml P , 40, 720ml P , 14, 2
3-1 3-1 20 2600, 20, 360ml P.35 3-2 3-2 16 2700, 16, 280ml P.35 3-3 3-3 20 2600, 20, 360ml P.35 3-4 3-4 19 2600, 19, 340ml P.35 3-5 3-5 20 2900, 20, 360ml P.35 3-6 3-6 18 3000, 18, 320ml P.35 3-7 3-7 18
瀬田唐橋景観検討について
3 3 12,174 /12hr 1,110 /12hr 3,066 /12hr 172.0m 51.75m 23.5+5@25.0+23.5m 3@17.25m 14.0m 15.0m 5 6 2009 12 3 2010 2 25 6/22 8/24 10/18 11/16 1/13 1797 16 15 15 13 6 (S49) 54 7 23-2 24 54 50
<967B92AC B82DC82BF82C382AD82E88C7689E68F912E706466>
16m80m 16 4 1100 17 1 1 1 2 2 4 2 3 3 2 3 2 1 5 1 1 18 1/100 18 1 2 3 2~4 1 1 1 2 26 () 27 5 28 300 29 () 30 31 32 20229 5/30 - (83-2041) 68 2 2 1 7 1 1 4 7 7 2 1 1 2 4 1 2 181222 1 // 2 // 3 // 4 /
１、開催年月日時刻及び場所
217 254 263 217 254 217 254 187 1.7 6 50 2 11 1 217 254 1 3.8 25 26 25,000 1500 4600 241,100 9,0001 300 130 17,000 217 254 203 10 217 254 3 26 261 26 10 50 217 217 217 13026 26 31410 () 141 26 142 26
DM
( ) FAX DM DM PR 300 - - - - - - - - - - - - - - - - - - 6 3 1 4 3 - - - - PR P173 FAX (2001) (2000) (1999) 1986 http://kimono-yamato.com/04-kiso/qa.html Q&A http://web.sfc.keio.ac.jp/~t00524sh/chousa/rich/kimonobegin.html
P01...R.s.[
234400 FFFFFFFFFFFFFF FFFFFFFFFFFFFF 0 2 660 99 ^ 2 4 5 6 7 3 230300 0 2 3 4 5 6 200230 666 752 22 300 30 3 300345 300500 23 300345 24 830945 230345 25 830945 230345 26 830945 230345 27 300 28 230345
Fig.1 MICs of penicillins against 24 strains of B. pertussis Fig.2 MICs of cepherns against 24 strains of B. pertussis Fig.3 MICs of macrolides against 24 strains of B. pertussis Fig.4 MICs of nalidixic
- 2006 4 25 2005 2006 5 9 5 11 2005 2006 2005 6 30 2005 303 25 2006 2006 11 9 2006 2007 - 2007 19 16 1500 FM NHKHBC ML WG HP ML PR WG WG WG WG 2007 TEL56-4646FAX56-2267 084-0922 2-2101 e-mail fukyu@kushiro-wetland.jp
CHEMOTHERAPY JUNE 1987 Table1 Media used *BHIB, brain heart infusion broth (Difco); /3 -NAD, S -nicotinamidoadeninedinucleotide (Sigma Chemical Co.);
VOL.35 S-2 CHEMOTHERAPY Fig.1 Chemical structure of carumonam CHEMOTHERAPY JUNE 1987 Table1 Media used *BHIB, brain heart infusion broth (Difco); /3 -NAD, S -nicotinamidoadeninedinucleotide (Sigma Chemical
MAWN8UP MAWN7UP MAWN6UP 3 3 3 5 4 3 3 3 3 4 3 3 4 4 3 3 4 4 3 3 4 4 3 3 4 3 3 4 3 3 3 4 3 4 5 3 3 4 5 3 4 3 5 4 3 5 6 6 3 4 5 6 7 54 50 40 30 58 50 40 30 6 50 40 30 8.0 7.0 6.0 5.0 4.0.0 0.5 3 9
6.5 5.5 900 1235 915 1250 940 1315 950 1320 1015 1355 1025 1405 1035 1435 1100 1455 1150 1
6.5 5.5 900 1235 915 1250 940 1315 950 1320 1015 1355 1025 1405 1035 1435 1100 1455 1150 1 2 3 * (* ) 4 5 6 7 8 9 10 18701949 () 31870 5 12 71874 10 18401925 131880 3 18381903 441911 11 1,600 241949 1
取扱説明書
TE-300 C n n 14-0% n n n n n n n n n n n n OP PGM m l o J R t m v Å x u 1 9 0 ^. K E [ P p !,!' L - % s c w D n n n n n n n n n m n n m n n n l l 1 1200!!200 2 3 g 2000 g!200 800 m K l 1 300! 800 "
(0 5 ) 11 Tel:251152 (0 5 ) 610 Tel:239646 (0 2 ) 22 Tel:354152 (0 2 ) 303 Tel:312000 (2 5 ) 218 Tel:310335 (0 2 ) 215 Tel:317788 (0 5 ) (0 5 ) Tel:382128 (0 5 ) 916 Tel:320510 (1 5 ) 410 Tel:225725 5-15
Key words: verocytotoxin-producing Escherichia coli, enterohemorrhagic Escherichia coli, Beutin' s blood agar
Key words: verocytotoxin-producing Escherichia coli, enterohemorrhagic Escherichia coli, Beutin' s blood agar Table1 @ Number of strains used in each experiment *hemolysis on Beutin' s blood agar plate
事業報告書
22 23 202,803 144,683 58,120 120,411 117,455 2,956 59.6 81.3 21.7% 22 23 62,677 56,001 6,676 57,734 61,454 3,720 120,411 117,455 2,956 47,092 13,255 33,837 19,397 7,666 11,731 3,546 401 3,145 3,290 1,546
CHEMOTHERAPY OCT. 1994 Tazobactam Piperacillin Fig. I. Chemical structures of tazobactam and piperacillin. Table 1. Media used for preculture and MIC determination BHIB: Brain heart infusion broth (Difco),
1 2 3 4 10 5 30 87 50 20 3 7 2 2 6 3 70 7 5 10 20 20 30 14 5 1,000 24 112 2 3 1 8 110 9 JR 10 110 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 25 30 31 32 25 A 33 B C D E F G PR PR or 34 35
00_Cover.pmd
SS-100/200/300/500 14443 Rev. A 1-1 1-1 1-2 2-1 2-2 3-1 3-2 3-3 3-4 4 1 2 3 7 5 6 2 3 4 5 6 1 7 2 8 3 9 4 10 5 11 6 12 1 7 3-5 S E 3 KIV 3.5mm 2 x4 KIV 2.0mm 2 x2 E 3 KIV 2.0mm 2 x1 M 7 1 2 3 4 5 6 M
23 3 11 21 24 28 4 31,371 20,822 34,511 21,720 12,278 9,574 7,502 137,778 1 69 83.49% 70 15.55% 0.96 3.61% 40 1.19% 1055 29.65% 28 10 1 2 230,250 43,150 656 138,000 137,832 137,820 121,000 30,000 246,800
untitled
2030 600 576 30 415 340 70 100 170 1 2 12 11 35 11 4 80 33 42 5 18 3 27 56 36 17 3 11 3 3,232 18 4 1 1,820 777 846 197 43.730 7 3 4 380,963 151,240 121,139 87,332 70,643 59,024 44,763 42,305 42,086 36,475
01_20.eps
3rd International Workshop on Japan Association for Food Function Clinical Research program Udayana Univ. / JAFCAR Joint Workshop 2009 in Bali 3rd International Workshop on Japan Association for Food Function
農林漁家民宿の女性経営者が
28 29 30 31 32 NA 33 NA 34 NA NA 35 NA 36 37 38 39 NA 40 41 NA NA 42 NA NA 43 NA NA 44 NA PR PR PR 45 PR PR PR PR FAX 46 FAX NA NA 47 NA NA 48 NA 49 NA 50 NA 51 NA NA 52 NA NA 53 GT NA 54 NA 55 NA 56 57
平成１７年度後期
00 OHP ( OHP ) Code L00 L00 L0 L0 L00 L0 L00 L00 L00 L0 L0 L00 L00 L00 L00 L0 L00 L00+L00 L00 L0 L00 L00+L00 L00 K K K K K K L0 L0 L0 L0 L L L L L L L L L L L L L L L L L L L L L L L L L L L L L L00
untitled
1 2 3 4 () 5 6 7 8 9 10 2 22 3 11 12 13 2 1-14 1 4 1 18 4 1 4 () 15 16 17 18 19 20 21 () 26 2 22 23 24 26 2 25 26 27 1 NPO 28 29 30 - 1 31 32 33 34 35 1 36 37 - 38 26 2 39 26 2 40 41 61 42 43 44 45 3 6
untitled
1 2 3 4 () 5 6 7 8 9 10 2 22 3 11 12 13 2 1-14 1 4 1 18 4 1 4 () 15 16 17 18 19 20 21 () 26 2 22 23 24 26 2 25 26 27 1 NPO 28 29 30 - 1 31 32 33 34 35 1 36 37 - 38 26 2 39 26 2 40 41 61 42 43 44 45 3 6
本組よこ／根間：文１１－１１＿Ｐ１３１－１５８
131 132 pp 133 134 a b 135 S pp S 136 a p b p S 137 p S p p H a p b 138 p H p p 139 T T pp pp a b c S a Sp a 140 b c d Sp a b c d e Spp a 141 b c d S a b c d S pp a b 142 c d e S S S S S S S 143 S S S
untitled
ver. 3.3JT EVENING PRIMROSE EXTRACT 1 - PMS 1 2 1 4 Oenothera laciniata Oenothera striata Oenothera biennis Oenothera erythrosepala - 2 80 60 40 20 0 1. 2 3 PGGPAC 2. 3 4 ESR3.5 10 5 /g 4 3 1 Helicobacter
988 CHEMOTHERAPY NOV. 1971
988 CHEMOTHERAPY NOV. 1971 VOL. 19 NO. 8 CHEMOTHERAPY 989 Effect of medium-ph and inoculum size on activity of SB-PC heart infusion agar, mcg/ml Sensitivity distribution of Staphylococci to SB-PC in surgical